Cargando…
Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
Elesclomol is a first-in-class investigational drug currently undergoing clinical evaluation as a novel cancer therapeutic. The potent antitumor activity of the compound results from the elevation of reactive oxygen species (ROS) and oxidative stress to levels incompatible with cellular survival. Ho...
Autores principales: | Blackman, Ronald K., Cheung-Ong, Kahlin, Gebbia, Marinella, Proia, David A., He, Suqin, Kepros, Jane, Jonneaux, Aurelie, Marchetti, Philippe, Kluza, Jerome, Rao, Patricia E., Wada, Yumiko, Giaever, Guri, Nislow, Corey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256171/ https://www.ncbi.nlm.nih.gov/pubmed/22253786 http://dx.doi.org/10.1371/journal.pone.0029798 |
Ejemplares similares
-
A Global Perspective of the Genetic Basis for Carbonyl Stress Resistance
por: Hoon, Shawn, et al.
Publicado: (2011) -
Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast
por: Ericson, Elke, et al.
Publicado: (2008) -
Chromatin is an ancient innovation conserved between Archaea and Eukarya
por: Ammar, Ron, et al.
Publicado: (2012) -
The Yeast Deletion Collection: A Decade of Functional Genomics
por: Giaever, Guri, et al.
Publicado: (2014) -
Design, Synthesis and Characterization of a Highly Effective Inhibitor for Analog-Sensitive (as) Kinases
por: Klein, Michael, et al.
Publicado: (2011)